Description

(5aR,9aα)-6β-[2-[(1R,3aR,5R,8aR)-Decahydro-1-hydroxy-1,4,4-trimethyl-6-methylene-7-oxoazulen-5-yl]ethyl]-4,5,5a,6,7,8,9,9a-octahydro-7β-hydroxy-2,2,5aβ,7α-tetramethyl-1-benzoxepin-3(2H)-one is a high-purity, complex sesquiterpene lactone derivative of significant interest in advanced organic synthesis and pharmaceutical research. This compound serves as a critical chiral intermediate for the development of novel therapeutic agents, leveraging its intricate polycyclic framework. It is primarily utilized by R&D laboratories and pharmaceutical manufacturers engaged in the synthesis of bioactive molecules, particularly in anti-inflammatory and anticancer drug discovery pipelines.

Application

• Pharmaceutical Intermediate: Key chiral building block for the synthesis of novel drug candidates, especially in anti-inflammatory and oncology research.
• Advanced Organic Synthesis: Used in complex multi-step syntheses to construct intricate sesquiterpene-based molecular architectures.
• Medicinal Chemistry Research: Serves as a lead compound or precursor for structure-activity relationship (SAR) studies and bioactivity screening.
• Reference Standard: Employed as a high-purity analytical standard for method development and quality control in pharmaceutical analysis.
• Biochemical Research: Investigated for its potential interactions with biological targets and signaling pathways.
• Fine Chemical Production: Intermediate in the manufacture of specialized fine chemicals and advanced materials.

Basic Information

Product Name	(5aR,9aα)-6β-[2-[(1R,3aR,5R,8aR)-Decahydro-1-hydroxy-1,4,4-trimethyl-6-methylene-7-oxoazulen-5-yl]ethyl]-4,5,5a,6,7,8,9,9a-octahydro-7β-hydroxy-2,2,5aβ,7α-tetramethyl-1-benzoxepin-3(2H)-one
CAS No.	86766-01-0
Molecular Formula	C₃₀H₄₄O₅
Molecular Weight	484.67 g/mol
Synonyms	6β-[2-[(1R,3aR,5R,8aR)-Decahydro-1-hydroxy-1,4,4-trimethyl-6-methylene-7-oxoazulen-5-yl]ethyl]-4,5,5a,6,7,8,9,9a-octahydro-7β-hydroxy-2,2,5aβ,7α-tetramethyl-1-benzoxepin-3(2H)-one; (5aR,9aα)-6β-[2-[(1R,3aR,5R,8aR)-Decahydro-1-hydroxy-1,4,4-trimethyl-6-methylene-7-oxoazulen-5-yl]ethyl]-4,5,5a,6,7,8,9,9a-octahydro-7β-hydroxy-2,2,5aβ,7α-tetramethyl-1-benzoxepin-3-one; Sesquiterpene Lactone Derivative 86766-01-0; Complex Sesquiterpene Intermediate; Azulene-Benzoxepin Derivative
EINECS	Contact for details

Quality Control

Our (5aR,9aα)-6β-[2-[(1R,3aR,5R,8aR)-Decahydro-1-hydroxy-1,4,4-trimethyl-6-methylene-7-oxoazulen-5-yl]ethyl]-4,5,5a,6,7,8,9,9a-octahydro-7β-hydroxy-2,2,5aβ,7α-tetramethyl-1-benzoxepin-3(2H)-one is manufactured under strict quality control protocols to ensure batch-to-batch consistency and high purity suitable for research and development. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. Our quality system is designed to meet the rigorous demands of pharmaceutical intermediate supply.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to maintain product integrity.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 95.0%
Related Substances (HPLC)	Total impurities ≤ 5.0%
Any single impurity	≤ 2.0%
Residual Solvents (GC)	Complies with ICH guidelines
Water Content (KF)	≤ 1.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.